Eagle Pharmaceuticals
EGRX
#10440
Rank
HK$35.43 M
Marketcap
HK$2.73
Share price
0.00%
Change (1 day)
-56.15%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: HK$35.43 Million

As of February 2026 Eagle Pharmaceuticals has a market cap of HK$35.43 Million. This makes Eagle Pharmaceuticals the world's 10440th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$35.43 M-21.9%
2025HK$45.37 M-18%
2024HK$55.33 M-89.57%
2023HK$0.53 B-82.15%
2022HK$2.97 B-42.03%
2021HK$5.12 B9%
2020HK$4.70 B-26.24%
2019HK$6.37 B45.28%
2018HK$4.38 B-29.51%
2017HK$6.22 B-34.59%
2016HK$9.52 B-11.4%
2015HK$10.74 B536.79%
2014HK$1.68 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
HK$35.43 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.277 T 12,071,930.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.228 T 6,290,134.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$7.263 T 20,500,064.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$1.438 T 4,059,004.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$875.55 B 2,470,877.76%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$814.75 B 2,299,288.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$305.47 B 861,997.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel